Skip to main content

Technologies

39 results found
Life Sciences Pharmaceuticals / Nutraceuticals
Technologies
ID: 2021-010 Using the power of Junctional Adhesion Molecules combined with the target of CAR-T to inhibit cancer metastasis and eradicate tumors.
Technologies
ID: 2019-057 Production of D-Allulose (D-psicose) from Bovine Lactose or Milk/Whey Permeate
Technologies
ID: 2019-051 Researchers at BYU have discovered antioxidants that are significantly more effective than current available antioxidants.
Technologies
ID: 2019-022 Two isolates were used to inoculate alfalfa resulting in significant enhancement of plant growth in the presence of salt.
Technologies
ID: 2019-015 Recombinant human Gal-1 treatment improves membrane repair capacity, increases myogenic markers and decreases inflammation in dysferlin deficient myotubes, providing novel evidence regarding how Gal-1 favorably improves muscle function in LGMD2B.
Technologies
ID: 2019-011 This is a method for delivery of equol, equol analogs, and the combination of racemic equol/different percentage of equol isomers and equol analogs with other polyphenolic compounds like resveratrol for the prevention and treatment of radiation exposure.
Technologies
ID: 2019-006 Treatment for substance abuse by mechanical vibration of the spine.
Technologies
ID: 2018-057 and 2014-098 BYU has discovered monocytes in the blood that provide a direct correlation to dopamine levels in the brain.
Technologies
ID: 2018-037 This technology is based on the use of phages infecting a bacteria and, as a byproduct of phage infection, antimicrobial components are released that can kill nearby infectious pathogens